Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1999
03/23/1999US5885795 Methods of expressing angiostatic protein
03/23/1999US5885786 Methods for screening of substances for inhibition of multidrug resistance
03/23/1999US5885782 Microbiocide oligopeptide mixture comprising at least two amino acid sequences; fungicides for treating plant or human
03/23/1999US5885781 Regulation of cytokine synthesis and release
03/23/1999US5885777 A nucleotide sequence encoding an active phosphatidylinositol-3-kinase consisting of specific amino acid sequences or a nucleotide sequence which hybridizes with above nucleotide sequences after washing in low salt buffer
03/23/1999US5885776 Glaucoma compositions and therapeutic and diagnositic uses therefor
03/23/1999US5885768 Immunogenic peptides derived from the orf1, orf2, and orf3 regions of hepatitis e virus (hev), diagnostic reagents containing the peptide antigens, vaccine compositions containing the antigens, antibodies
03/23/1999US5885618 Compressible enzyme powder
03/23/1999US5885601 Delivering antibiotic directly to the uterine cavity or fallopian tube of the female in an amount effective to cause sterilization
03/23/1999US5885584 Improving and accelerating the remyelination of lesioned nerve fibers by administering a nerve growth factor for treating multiple sclerosis
03/23/1999US5885579 CTLA4 receptor and uses thereof
03/23/1999US5885577 Possess binding specificities that are similar to the binding specificities of the antibodies or receptors; may be used in place of antibodies in many assays or therapeutic applications
03/23/1999US5885576 Vaccines and methods for preventing and treating fescue toxicosis in herbivores
03/23/1999US5885575 Diagnosis and therapy of tumour metastases
03/23/1999US5885574 Antibodies which activate an erythropoietin receptor
03/23/1999US5885573 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
03/23/1999US5885572 Administering polypeptide or active fragment to treat bacterial infections
03/23/1999US5885568 Coccidiosis poultry vaccine
03/23/1999US5885567 Treatment of infection in fowl by oral administration of avian interferon proteins
03/23/1999US5884620 Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
03/23/1999CA2247735A1 Novel 5-membered ring heterocycles, their preparation, their use and pharmaceutical preparations comprising them
03/23/1999CA2127462C Treatment for asthma
03/23/1999CA2093513C Methods and compositions for suppressing allograft rejection in mammals
03/23/1999CA2072624C Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
03/23/1999CA2052713C Delivery of agents
03/23/1999CA2025858C Antihepatopathic composition
03/23/1999CA1340461C Alveolar surfactant proteins
03/23/1999CA1340456C Chimeric rodent/human immunoglobulins specific for tumor-associated antigens
03/23/1999CA1340455C Human preproinsulin-like growth factor i
03/23/1999CA1340454C Diuretic peptide and gene coding same
03/23/1999CA1340453C Human atrial natriuretic peptide and gene coding for same
03/22/1999CA2244239A1 Novel era
03/22/1999CA2244237A1 A human lig-1 homolog (hlig-1)
03/19/1999CA2211003A1 Human tumor necrosis factor receptor
03/18/1999WO1999013338A1 dsRNA/dsRNA-BINDING PROTEIN METHODS AND COMPOSITIONS
03/18/1999WO1999013097A1 Stabilization of helicobacter urease
03/18/1999WO1999013095A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999WO1999013088A1 Novel human manganese superoxide dismutase proteins
03/18/1999WO1999013086A1 PROTEIN WITH THE AMINO ACID SEQUENCE OF Δ7 STEROL REDUCTASE, ISOLATED cDNA MOLECULE CODING FOR SAID PROTEIN, RECOMBINANT DNA VECTOR AND BIOLOGICALLY ACTIVE COMPOSITIONS CONTAINING SAID PROTEIN OR SAID cDNA MOLECULE
03/18/1999WO1999013082A1 Cxc chemokine
03/18/1999WO1999013081A1 EXPRESSION OF GONADOTROPINS IN $i(DICTYOSTELIUM)
03/18/1999WO1999013080A1 Beta-defensins
03/18/1999WO1999013078A1 Cysteine rich receptors-train
03/18/1999WO1999013076A1 Mpl ligand analogs
03/18/1999WO1999013074A1 Protein having activity of activiting nerve cell functions
03/18/1999WO1999013071A1 Human papilloma virus inhibition by anti-sense oligonucleotides
03/18/1999WO1999013067A2 Hypoxia inducible promoter
03/18/1999WO1999013066A1 Secreted proteins and polynucleotides encoding them
03/18/1999WO1999013063A1 Factor vii fragments and analogs thereof and their use in the treatment of blood clottng disorders
03/18/1999WO1999013062A1 Factors vii fragments and analogs thereof and their use in the treatment of blood clotting disorders
03/18/1999WO1999013057A1 CLASS I-TYPE LYSYL-tRNA SYNTHETASE
03/18/1999WO1999013055A1 Human sigma receptor
03/18/1999WO1999013054A2 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
03/18/1999WO1999013053A1 Genetically modified tumor-targeted bacteria with reduced virulence
03/18/1999WO1999012974A1 Monoclonal antibodies that bind testosterone
03/18/1999WO1999012970A1 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds
03/18/1999WO1999012969A1 Treatment of obesity
03/18/1999WO1999012968A2 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999WO1999012967A1 Retro-inverso neurotrophic and analgesic peptides
03/18/1999WO1999012966A1 Peptides comprising an immunodominant sequence derived from human myelin oligodendrocyte glycoprotein
03/18/1999WO1999012965A2 April- a novel protein with growth effects
03/18/1999WO1999012964A2 Kay - a novel immune system protein
03/18/1999WO1999012963A2 Cysteine rich receptors: trail
03/18/1999WO1999012962A1 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases
03/18/1999WO1999012961A1 Estrogen receptor
03/18/1999WO1999012958A2 Ampullosporin, method for producing same and its use
03/18/1999WO1999012640A1 Coated particles, methods of making and using
03/18/1999WO1999012576A2 Methods and compositions for treating cardiac and renal disorders with atrial natriuretic peptide and tissue kallikrein gene therapy
03/18/1999WO1999012574A1 Improvements in or relating to expression of immunogenic substances
03/18/1999WO1999012573A1 Improvements in or relating to regulation of t cell activation
03/18/1999WO1999012572A1 Compounds and method for the prevention and treatment of diabetic retinopathy
03/18/1999WO1999012569A1 Methods for increasing cd4+ t-lymphocyte counts in hiv-infected patients by the administration of gm-csf
03/18/1999WO1999012567A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999WO1999012566A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
03/18/1999WO1999012563A2 Mucosal cytotoxic t lymphocyte responses
03/18/1999WO1999012561A2 FRACTURE HEALING USING PTHrP ANALOGS
03/18/1999WO1999012560A1 Synergistic effects of op/bmp morphogens and gdnf/ngf neurotrophic factors
03/18/1999WO1999012559A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999WO1999012558A1 Inhibitors of collagen assembly
03/18/1999WO1999012557A1 Novel prokaryotic polynucleotides, polypeptides and their uses
03/18/1999WO1999012533A1 A method of modulating cellular activity
03/18/1999WO1999012524A1 MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs)
03/18/1999WO1999012523A1 Modulation of drug loading in multivesicular liposomes
03/18/1999WO1999012522A1 High and low load formulations of igf-i in multivesicular liposomes
03/18/1999WO1999012414A1 Transplacental delivery of oligonucleotides
03/18/1999WO1999000410A3 Human extracellular matrix proteins
03/18/1999WO1999000140A3 Accelerating animal hoof growth with somatotropin
03/18/1999WO1998058955A3 Nuclear matrix targeting peptides and uses therefor
03/18/1999WO1998058954A3 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens
03/18/1999WO1998058953A3 Surface exposed proteins from chlamydia pneumoniae
03/18/1999WO1998058635A3 Method for the treatment of cancer with exochelins of mycobacterium tuberculosis
03/18/1999WO1998058629A3 Preparation of pharmaceutical compositions
03/18/1999WO1998058055A3 Antisense nucleic acids targeting hbv
03/18/1999WO1998057987A3 Irs-p53h, human insulin receptor tyrosine kinase substrate
03/18/1999WO1998057982A3 Aib1, a steroid receptor co-activator
03/18/1999WO1998056909A3 Secreted proteins and polynucleotides encoding them
03/18/1999WO1998055510A3 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
03/18/1999WO1998054302A3 Human lysophosphatidic acid acyltransferase
03/18/1999WO1998053063A3 Mammalian cell transduction for use in gene therapy
03/18/1999WO1998052614A3 Composition and method for enhancing transport across biological membranes
1 ... 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 ... 3163